In this study, CD44‐positive (CD44+Fbs) and CD44‐negative carcinoma‐associated fibroblasts (CD44−Fbs) were isolated and cocultured with breast cancer cells for analysis of cell survival and drug resistance. Here, CD44 is linked to breast carcinoma.